日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group

指导多发性硬化症护理:21世纪多发性硬化症指导小组对2013年共识声明的更新

Alroughani, Raed; Celius, Elisabeth G; Gray, Helen; Kasilingam, Elisabeth; Kruger, Paola; Montague, Amanda; Oreja-Guevara, Celia; Plant, Amber; Pontaga, Maija; Rieckmann, Peter; Ritter, Leslie; Sumelahti, Marja-Liisa

Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans

中重度急性偏头痛发作:关于在个体化治疗方案中使用曲坦类药物及曲坦类药物联合非甾体抗炎药的观点文件

Goadsby, Peter J; Sinclair, Alexandra J; Afridi, Shazia K; Lucas, Christian; Mawet, Jerôme; Lanteri-Minet, Michel; Moisset, Xavier; Diener, Hans Christoph; Gaul, Charly; Jürgens, Tim Patrick; Sumelahti, Marja-Liisa; Del Rio, Margarita Sanchez; Del Pozo-Rosich, Patricia; Russo, Antonio; Barbanti, Piero

Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial

动态振荡刺激预防慢性偏头痛:一项随机、双盲、假刺激对照试验

Hoffmann, Jan; Kaube, Holger; Rimmele, Florian; Jürgens, Tim P; Nissilä, Markku; Gaul, Charly; Kallela, Mikko; Keski-Säntti, Petra; Sumelahti, Marja-Liisa; Straube, Andreas; Lewis, David; Hoffmann, Vanessa; Wirtz, Larissa; Rempel, Annette; Böhm, Olaf; May, Arne

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy

绝经后多发性硬化症女性的免疫代谢谱分析:脂肪因子和激素治疗的作用

Juutinen, Laura; Ahinko, Katja; Hagman, Sanna; Kokkola, Tarja; Kärkkäinen, Sari; Jääskeläinen, Olli; Hämäläinen, Mari; Basnyat, Pabitra; Vistbacka, Julia; Herukka, Sanna-Kaisa; Moilanen, Eeva; Sumelahti, Marja-Liisa

Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study

在1140名偏头痛患者中,接受至少6个月治疗的fremanezumab的长期真实世界疗效和安全性:泛欧洲PEARL研究的第三次中期分析

Ashina, Messoud; Mitsikostas, Dimos D; Amin, Faisal Mohammad; Kokturk, Pinar; Schankin, Christoph J; Sahin, Gurdal; Pozo-Rosich, Patricia; Dorman, Paul J; Nežádal, Tomáš; Poole, Anne Christine; Martins, Isabel Pavão; Sumelahti, Marja-Liisa; Ramirez Campos, Verena; Ahn, Andrew H; Akcicek, Hasan; Tassorelli, Cristina

Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria-a nationwide population-based registry study over five decades

在诊断标准不断演变的时代,多发性硬化症的发病率和患病率——一项跨越五十年的全国性人口登记研究

Maunula, Anna; Laakso, Sini M; Viitala, Matias; Soilu-Hänninen, Merja; Sumelahti, Marja-Liisa; Atula, Sari

Stable excess mortality in a multiple sclerosis cohort diagnosed 1970-2010

1970-2010年间诊断的多发性硬化症队列中稳定的超额死亡率

Sumelahti, M-L; Verkko, A; Kytö, V; Sipilä, J O T

Sumatriptan-naproxen sodium in migraine: A review

舒马曲坦-萘普生钠治疗偏头痛:一项综述

Wilcha, Robyn-Jenia; Afridi, Shazia K; Barbanti, Piero; Diener, Hans Christoph; Jürgens, Tim Patrick; Lanteri-Minet, Michel; Lucas, Christian; Mawet, Jerôme; Moisset, Xavier; Russo, Antonio; Sacco, Simona; Sinclair, Alexandra J; Sumelahti, Marja-Liisa; Tassorelli, Cristina; Goadsby, Peter J

Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families

多基因风险为芬兰偏头痛家族中的ICHD-3诊断标准提供了生物学有效性。

Häppölä, Paavo; Gormley, Padhraig; Nuottamo, Marjo E; Artto, Ville; Sumelahti, Marja-Liisa; Nissilä, Markku; Keski-Säntti, Petra; Ilmavirta, Matti; Kaunisto, Mari A; Hämäläinen, Eija I; Ripatti, Samuli; Pirinen, Matti; Wessman, Maija; Palotie, Aarno; Kallela, Mikko

My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland

我的偏头痛之声调查:疾病对芬兰医疗资源利用、个人和工作生活的影响

Sumelahti, Marja-Liisa; Sumanen, Markku; Sumanen, Merika S; Tuominen, Samuli; Vikkula, Johanna; Honkala, Sanna M; Rosqvist, Stina; Korolainen, Minna A